Methods of treatment and prevention of diseases associated with release of eutrophil elastase and IL-8 by administration of TFPI, and analogs of TFPI are disclosed. Methods of determining efficacy of treatment with TFPI, patient's responsiveness to treatment with TFPI and the ultimate determination of patient prognosis are also disclosed.

Compositions and methods relating to the regulation of transport of cholesterol into the mitochondria of a cell and, therefore, for the regulation of steroidogenesis are provided. Compositions include nucleic acid molecules encoding a steroidogenic acute regulatory protein (StAR), StAR protein molecules and peptides having amino acid sequences as disclosed herein, and anti-StAR antibodies. Methods include immunoassays using anti-StAR antibodies and nucleic acid based screening methods for pathol...

Plants in which flavonol activity has been impaired are conditionally male fertile (CMF), and male fertility can be rescued or restored by providing fertility restoring flavonols at pollen sites in the plant. Although viable pollen is produced by flavonol deficient plants, pollen germination and tube growth are severely reduced both in vivo and in vitro, resulting in plants which are self sterile. However, by contacting pollen of the plant with an amount of a fertility restoring flavonol effecti...

A method for decreasing metalloproteinase activity in a patient that comprises the step of administering to said patient a therapeutic composition comprising the cytokine oncostatin-M, or a biologically active fragment, mutant, analog or fusion construct thereof. Also, a method for increasing TIMP activity in a patient that comprises the step of administering to said patient a therapeutic composition comprising the cytokine oncostatin-M, or a biologically active fragment, mutant, analog or fusio...

A current regulator (60, 90, and 100) provides current regulation. The current regulator (60, 90, and 100) has a bias generator (14) which compares a generated voltage, V.sub.ref, with a feedback voltage generated in accordance with an output current provided in a reference circuit (57, 58, and 59). The current regulator (60, 90, and 100) operates as a bias circuit to minimize the quiescent currents for efficiently providing regulated output currents in current sink circuit (26). The current in ...

Androsta-5,7-diene-3.beta., 17.beta.-diol, its esters and ethers and related compounds wherein ring opening of the steroid ring system between carbons 9 and 10 has occurred are active as regulators of immune response and cell proliferation and differentiation.

A pressure regulation valve is disclosed which comprises a housing including first and second ports, a support for slidably supporting a tubular member defining a valve seat against which a valve element is engageable. The tubular member and valve element are spring biased into engagement with one another. In use, the application of pressurized fuel to the first port pushes the tubular member against the stop, the valve element being able to leave the valve seat in order to permit fuel flow thro...

The invention is directed to a hydrolytically polymerized polycaprolactam with new chain regulation, whereby the polymerization of caprolactam (I) is carried out with 0.1-0.7 weight percent of an aromatic dicarboxylic acid (II), 0.01-0.7 weight percent of an aliphatic or cycloaliphatic diamine (III) that carries a primary and a tertiary amino group, and/or 0.01-0.7 weight percent 4-amino-2,2,6,6-tetraalkyl piperidine (IV), whereby the quantities of constituents I through IV add up to 100 weight ...

The present invention relates to a product and process for regulating the activity of T cells using major histocompatibility complexes (MHC) stably linked to antigenic peptides. Disclosed is an antigenic peptide covalently linked to a major histocompatibility complex (MHC) protein by a novel linker, thereby enabling the formation of a stable peptide-MHC complex, alone or in combination with additional MHC protein chains, capable of being recognized by a T cell receptor (TCR). Also disclosed is a...

The present invention provides a human regulator of gene transcription (HRGT) and polynucleotides which encode HRGT. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for treating disorders associated with expression of HRGT.